BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Shareholders Explore Strategic Options for Unisense FertiliTech A/S


2/21/2012 12:11:35 PM

AARHUS, Denmark, February 21, 2012 /PRNewswire/ --

After successfully developing Unisense FertiliTech A/S towards full commercialization of the EmbryoScope® Time-lapse System, the shareholders of FertiliTech announce that they have initiated a review of strategic ownership options for the Company which may lead to a sale in whole or in part. There is no specific timetable for this strategic review.

Unisense FertiliTech was founded in 2003 to develop technology to improve embryo assessment in human assisted reproduction. FertiliTech focuses on the promising area of time-lapse enabled embryo assessment and has developed the EmbryoScope® Time-lapse system, the EmbryoViewer® Workstation (Software) and related products. Through its products and groundbreaking technology, FertiliTech offers the IVF industry a paradigm shift and a future strategic platform for clinics, which will lead to higher pregnancy success rates and improved value for clinics and patients.

The Unisense group of companies, including FertiliTech, is focused on research and development of novel technologies for selected niches of the medical and life science industries. FertiliTech is now at the stage where the next step is full commercialization and further roll-out on a global scale. In addition to already launched products, FertiliTech has a highly attractive pipeline of new products in the development phase which hold significant commercial potential within the IVF industry. The Company is currently in a position to execute its strategy and roll-out plan on a stand-alone basis in the coming years; However FertiliTech's shareholders see even greater growth under a new strategic ownership supporting the further commercialization and development of the pipeline.

FertiliTech's shareholders have retained SEB Enskilda Corporate Finance to assist in the evaluation of strategic ownership options for the Company.

More information about the Company is available at http://www.fertilitech.com

For further information please contact:
CFO Michael Reeslev
+45-89449500
Email: mkr@fertilitech.com


SOURCE Unisense FertiliTech A/S


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->